Re: OTC Expert & Grey Market Restrictions
in response to
by
posted on
Nov 22, 2022 02:29PM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
After some more searching, a good discussion is posted here.
Notably:
Despite the restrictions on who can view quotations, the Expert Market does not impose restrictions on who can trade securities. Rule 15c2-11 governs a broker’s ability to submit, publish or distribute quotations (i.e. bids and offers) in OTC securities. The Rule does not apply to the underlying transactions or the ability of an investor to buy or sell a security.
(emphasis mine)